Wen-Xin Decoction ameliorates vascular endothelium dysfunction via the PI3K/AKT/eNOS pathway in experimental atherosclerosis in rats-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Wen-Xin Decoction ameliorates vascular endothelium dysfunction via the PI3K/AKT/eNOS pathway in experimental atherosclerosis in rats

Published:2015-12 Issue:1 Volume:16 Page:
ISSN:1472-6882
Container-title:BMC Complementary and Alternative Medicine
language:en
Short-container-title:BMC Complement Altern Med

Author:

Li Tongda,Li Dongmei,Xu Hui,Zhang Huamin,Tang Danli,Cao Hongxin

Publisher

Springer Science and Business Media LLC

Subject

Complementary and alternative medicine,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12906-016-1002-7.pdf

Reference27 articles.

1. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3, e442.

2. Ross R, Glomset JA. The pathogenesis of atherosclerosis (first of two parts). N Engl J Med. 1976;295:369–77.

3. Ross R. Atherosclerosis–an inflammatory disease. N Engl J Med. 1999;340:115–26.

4. Stasch JP, Schmidt P, Alonso-Alija C, Apeler H, Dembowsky K, Haerter M, et al. NO- and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle. Br J Pharmacol. 2002;136:773–83.

5. Williams B. Angiotensin II, and the pathophysiology of cardiovascular remodeling. Am J Cardiol. 2001;87:10C–7.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Procyanidin B1 Protects HPAEpiCs from Lipopolysaccharide-mediated Inflammation Damage by Modulating the eNOS/NO/cGMP Pathway;J BIOL REG HOMEOS AG;2024

2. As-IV improves LPS-induced vascular endothelial dysfunction by inhibiting calpain-1/PI3K/Akt Signaling;2023-08-07

3. As-IV improves LPS-induced vascular endothelial dysfunction by inhibiting calpain-1/PI3K/Akt Signaling;2023-08-02

4. A mechanistic study on the Wenxin formula for atherosclerosis treatment based on miRNA sequencing and network pharmacology;Pharmacological Research - Modern Chinese Medicine;2023-06

5. Recent advances of traditional Chinese medicine for the prevention and treatment of atherosclerosis;Journal of Ethnopharmacology;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3